Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source
Credit: Reuters/Shannon Stapleton
Allergan Chief Executive David Pyott speaks during an interview in New York July 8, 2014.
The boards of the two companies are expected to meet to review a cash-and-stock deal, and an agreement could be announced as early as Monday, according to the report.
(Reporting by Caroline Valetkevitch; Editing by Jeffrey Benkoe)
Post a Comment for "Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source"